« back

Movember: Global Collaborative Program to Develop a Personalised, Dynamic, Risk-Adapted Approach to Active Surveillance for Prostate Cancer

  Sunday, 25 Sep 2022 | Funding Deadline

Movember is pleased to invite expressions of interest (EOI) from suitably qualified and experienced research teams to participate in a new, global, collaboratively designed program in active surveillance (AS) for prostate cancer. The aim of this program is to accelerate the development of a personalised, dynamic
, risk-adapted approach to AS, to reduce unnecessary tests and treatments in men with low and some intermediate risk prostate cancer.

Deadline for proposals: 25 September 2022
Find out more here